Research output

  1. Anti-C5a antibody vilobelimab treatment and the effect on biomarkers of inflammation and coagulation in patients with severe COVID-19: a substudy of the phase 2 PANAMO trial

    Research output: Contribution to journal › Article › Academic › peer-review

  2. Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Reply to: Microbial Burden-associated Cytokine Storm May Explain Non-Resolving ARDS in COVID-19 Patients

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

View all (15) »

ID: 10557548